Why Triglycerides Are Elevated in Diabetes
Diabetes causes elevated triglycerides through two primary mechanisms: increased hepatic production of triglyceride-rich VLDL particles and impaired clearance of these particles from the bloodstream, both driven by insulin deficiency or insulin resistance. 1, 2
Primary Pathophysiologic Mechanisms
Increased Hepatic Triglyceride Production
The most common abnormality in diabetic hypertriglyceridemia is overproduction of VLDL triglycerides by the liver 1, 3. This occurs through several interconnected pathways:
Excess free fatty acid flux: In insulin resistance and visceral obesity, increased lipolysis of adipose tissue releases excessive free fatty acids that return to the liver, providing substrate for triglyceride synthesis 1, 4
Increased de novo lipogenesis: Hyperinsulinemia (paradoxically present in type 2 diabetes despite insulin resistance) stimulates hepatic synthesis of fatty acids from carbohydrates 1
Hepatic insulin resistance: When the liver becomes insulin resistant, it fails to suppress apoB synthesis and VLDL secretion normally. In healthy states, insulin reduces apoB synthesis and VLDL secretion, but this regulatory mechanism is lost 1
The result is secretion of more VLDL particles that are larger and more triglyceride-enriched, with higher apoC-III content 1.
Impaired Triglyceride Clearance
The second major mechanism is reduced clearance of triglyceride-rich lipoproteins from circulation 1:
Decreased lipoprotein lipase (LpL) activity: In untreated or poorly controlled type 1 diabetes, insulin deficiency directly reduces LpL activity, which is essential for hydrolyzing triglycerides in VLDL and chylomicrons 2
Saturation of clearance pathways: When triglyceride levels become moderate to severe (≥200 mg/dL), the LpL removal system becomes saturated, further impairing clearance 1
Defective chylomicron metabolism: In type 2 diabetes, defective removal of both chylomicrons and chylomicron remnants contributes to postprandial hypertriglyceridemia 2
Clinical Context and Severity
Type 1 vs Type 2 Diabetes
Hypertriglyceridemia occurs more frequently in type 2 than type 1 diabetes 1. In type 1 diabetes, triglycerides correlate closely with glycemic control and can normalize with adequate insulin therapy 2. In type 2 diabetes, mild hypertriglyceridemia typically persists even with treatment due to underlying central obesity and insulin resistance 1.
The Role of Insulin Resistance
While insulin resistance is strongly associated with hypertriglyceridemia, the contribution of insulin resistance to triglyceride overproduction is variable among individuals 1. Some patients with severe insulin resistance may have relatively normal triglycerides (notably in African-Americans), while others with similar insulin sensitivity have markedly elevated levels 1. This suggests additional genetic and metabolic factors modulate the relationship.
Secondary Factors That Amplify Hypertriglyceridemia
Diabetes commonly coexists with other conditions that worsen hypertriglyceridemia 1:
- Central obesity and metabolic syndrome
- High carbohydrate intake, especially simple sugars and fructose
- Alcohol consumption
- Medications (thiazide diuretics, beta-blockers, oral estrogens)
- Renal disease (nephrotic syndrome, renal failure)
- Hepatic steatosis
When diabetes is superimposed on an underlying genetic dyslipidemia, severe or very severe hypertriglyceridemia (≥1,000 mg/dL) can develop, creating risk for acute pancreatitis 1.
Clinical Implications
Appropriate diabetes management reduces triglyceride levels 1. In type 1 diabetes, insulin therapy rapidly reverses hypertriglyceridemia by restoring LpL activity and reducing hepatic VLDL overproduction 2. In type 2 diabetes, glycemic control should be optimized first, particularly when triglycerides are markedly elevated with insulin insufficiency 5.
The characteristic diabetic dyslipidemia pattern—elevated triglycerides, low HDL cholesterol, and small dense LDL particles—represents the major link between diabetes and increased cardiovascular risk 6, 7. This atherogenic profile results from the triglyceride overproduction described above, with subsequent lipid exchange processes mediated by cholesterol ester transfer protein (CETP) 4.
Key Clinical Pitfall
Do not assume all hypertriglyceridemia in diabetes is simply due to poor glucose control. Always evaluate for secondary causes including medications, alcohol use, hypothyroidism, renal disease, and underlying genetic dyslipidemias 1. The combination of diabetes with these secondary factors can precipitate severe hypertriglyceridemia and pancreatitis risk.